Measurement of brain natriuretic peptide in plasma samples and cardiac tissue extracts by means of an immunoradiometric assay method

REFERENCES

• Espiner EA. Hormones of the cardiovascular system. In: DeGroot LJ, editor. Endocrinology. 3rd ed. WB Saunders, 1995; 2895–916.
   Google Scholar
• Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 321 —8.
   Google Scholar
• Sonmez F, Mir S, Ozyurek AR, Cura A. The adjustment of post-dialysis dry weight based on non-invasive measurements in children. Nephrol Dial Transplant 1996; 11: 1564–7.
   PubMed Web of Science ®Google Scholar
• Clerico A, Iervasi G, Mariani G. Clinical relevance of the measurement of cardiac natriuretic peptide hormones in humans. Horm Metab Res 1999; 31: 487— 98.
   PubMed Web of Science ®Google Scholar
• Clerico A, Iervasi G, Del Ry S, Giannessi D. Immunoassay methods for the measurement of natriuretic cardiac hormones (ANP, BNP, and related peptides) in humans. J Clin Ligand Assay 1999; 22: 194–204.
   Google Scholar
• Struthers AD. Plasma concentrations of brain natriuretic peptide: will this new test reduce the need for cardiac investigations? [editorial]. Br Heart J 1993; 70: 397–8.
   PubMedGoogle Scholar
• Bonow RO. New insights into the cardiac natriuretic peptides [editorial]. Circulation 1996; 93: 1946–50.
   PubMed Web of Science ®Google Scholar
• Cowie MR, Struthers AD, Wood DA, Coats AJS, Thompson SG, Poole-Wilson PA, Sutton GC. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997; 350: 1347–51.
   Google Scholar
• Stein BC, Levin RI. Natriuretic peptides: physiol-ogy, therapeutic potential, and risk stratification in ischemic heart disease. Am Heart J 1998; 135: 914— 23.
   PubMed Web of Science ®Google Scholar
• Sagnella GA. Measurement and significance of circulating natriuretic peptides in cardiovascular diseases. Clin Sci 1998; 95: 519–29.
   PubMed Web of Science ®Google Scholar
• Clerico A, Iervasi G, Del Chicca MG, Emdin M, Maffei S, Nannipieri M, et al. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immu-noradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest 1998; 21: 170–8.
   PubMed Web of Science ®Google Scholar
• Davidson NC, Naas AA, Hanson JK, Kennedy NSJ, Coutie WJ, Struthers AD. Comparison of atrial natriuretic peptide, B-type natriuretic pep-tide, and n-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. Am J Cardiol 1996; 77: 828–31.
   PubMed Web of Science ®Google Scholar
• Murdoch DR, Byrne J, Morton JJ, McDonagh TA, Robb SD, Clements S, et al. Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice. Heart 1997; 78: 594–7.
   PubMed Web of Science ®Google Scholar
• Togashi K, Hirata Y, Ando K, Takei Y, Kawakami M, Marumo F. Brain natriuretic peptide-like immunoreactivity is present in human plasma. FEBS Lett 1989; 250: 235–7.
   PubMed Web of Science ®Google Scholar
• Lang CC, Coutie WJ, Khong TK, Choy AMJ, Struthers AD. Dietary sodium loading increases plasma brain natriuretic peptide levels in man. J Hypertens 1991; 9: 779–82.
   Google Scholar
• Mukoyama M, Nakao K, Hosada K, Suga S, Saito Y, Ogawa Y, et al. Brain natriuretic peptide, a novel cardiac hormone in humans. J Clin Invest 1991; 87: 1402–12.
   PubMed Web of Science ®Google Scholar
• Motwani JG, McAlpine H, Kennedy N, Struthers AD. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhi- bitor after myocardial infarction. Lancet 1993; 341: 1109–13.
   PubMed Web of Science ®Google Scholar
• Yandle TG, Richards AM, Gilbert A, Fisher S, Holmes S, Espiner EA. Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab 1993; 76: 832–8.
   PubMed Web of Science ®Google Scholar
• Tharaux PL, Dussaule JC, Hubert-Brierre J, Vahanian A, Acar J, Ardaillou R. Plasma atrial and brain natriuretic peptides in mitral stenosis treated by valvulotomy. Clin Sci 1994; 87: 67–77.
   Google Scholar
• Kono M, Yamauchi A, Tsuji T, Misaka A, Igano K, Ueki K, et al. An immunoradiometric assay for brain natriuretic peptide in human plasma. Kaku Igaku 1993; 13: 2–7.
   Google Scholar
• Iervasi G, Clerico A, Berti S, Pilo A, Vitek F, Biagini A, et al. ANP kinetics in normal men: in vivo measurement by a tracer method and correlation with sodium intake. Am J Physiol 1993; 264: F480–9.
   PubMed Web of Science ®Google Scholar
• Clerico A, Iervasi G, Berti S, Pilo A, Vitek F, Salvadori S, et al. In vivo measurement of ANP overall turnover and identification of its main metabolic pathways under steady state conditions in humans. J Endocrinol Invest 1995; 18: 194 — 204.
   PubMed Web of Science ®Google Scholar
• Iervasi G, Clerico A, Berti S, Pilo A, Biagini A, Bianchi R, Donato L. Altered tissue degradation and distribution of Atrial Natriuretic Peptide in patients with idiopathic dilated cardiomyopathy and its relationship with clinical severity of the disease and sodium handling. Circulation 1995; 91: 2018— 27.
   Google Scholar
• Clerico A, Del Chicca MG, Giganti M, Zucchelli GC, Piffanelli A. Evaluation and comparison of the analytical performances of two RIA kits for the assay of atrial natriuretic peptides (ANP). J Nucl Med All Sci 1990; 34: 81–7.
   PubMedGoogle Scholar
• Clerico A, Opocher G, Pelizzola D, Panzali AF, Andreone P, Del Chicca MG, et al. Evaluation of the analytical performance of RIA methods for measurement of ANP. J Clin Immunoassay 1991; 14: 251–6.
   Google Scholar
• Clerico A, Iervasi G, Manfredi C, Salvadori S, Marastoni M, Turchi S, et al. Preparation of mono-radio-iodinated tracers for studying the in vivo metabolism of atrial natriuretic peptide in humans. Eur J Nucl Med 1995; 22: 997— 1004.
   PubMedGoogle Scholar
• Pilo A, Zucchelli GC, Malvano R, Masini S. Main features of computer algorithms for RIA data reduction. Comparison of some different approaches for the interpolation of dose—response curve. J Nucl Med All Sci 1982; 26: 235–48.
   Google Scholar
• Jensen KT, Carstens J, Ivarsen P, Pedersen EB. A new, fast, and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases. Scand J Clin Lab Invest 1997; 57: 529–40.
   PubMed Web of Science ®Google Scholar
• Kuroski de Bold ML. Estrogen, natriuretic pep-tides and the renin— angiotensin system. Cardio-vasc Res 1999; 41: 524–31.
   PubMed Web of Science ®Google Scholar
• Buckley MG, Sethi D, Markandu ND, Sagnella GA, Singer DRJ, MacGregor GA. Plasma con-centrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. Clin Sci 1992; 83: 437–44.
   Web of Science ®Google Scholar
• Corboy C, Walker R, Simmonds MB, Wilkins GT, Richard AM, Espiner EA. Plasma natriuretic peptides and cardiac volume during acute changes in intravascular volume in haemodialysis patients. Clin Sci 1994; 87: 679–84.
   Web of Science ®Google Scholar
• Haug C, Metzele A, Steffgen J, Kochs M, Hombach V, Grunert A. Increased brain natriure-tic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure. Clin Invest 1994; 72: 430–4.
   PubMedGoogle Scholar
• Ishizaka Y, Yamamoto Y, Fukunaga T, Yokota N, Kida 0, Kitamura K, et al. Plasma correlation of human brain natriuretic peptides in patients on hemodialysis. Am J Kidney Dis 1994; 24: 461–72.
   Google Scholar
• Akiba T, Tachibana K, Togashi K, Hiroe M, Marumo F. Plasma human brain natriuretic peptide in chronic renal failure. Clin Nephrol 1995; 44 Suppl 1: S61–4.
   Google Scholar
• Ishizaka Y, Yamamoto Y, Tanaka M, Kato F, Ishizara Y, Yokota N, et al. Molecular forms of human brain natriuretic peptide (BNP) in plasma of patients on hemodialysis (HD). Clin Nephrol 1995; 43: 237–42.
   PubMed Web of Science ®Google Scholar
• Mukoyama M, Nakao K, Hosada K, Suga S, Saito Y, Ogawa Y, et al. Brain natriuretic peptide, a novel cardiac hormone in humans. J Clin Invest 1991; 87: 1402–12.
   PubMed Web of Science ®Google Scholar
• Ationu A, Burch M, Singer D, Littleton P, Carter ND. Cardiac transplantation affects ventricular expression of brain natriuretic peptide. Cardiovasc Res 1993; 27: 188–91.
   Google Scholar
• Ationu A, Sorensen K, Whitehead B, Singer D, Burch M, Carter ND. Ventricular expression of brain natriuretic peptide gene following orthotopic cardiac transplantation in children—a three year follow up. Cardiovasc Res 1993; 27: 2135–9.
   PubMed Web of Science ®Google Scholar
• Ationu A, Carter ND. Molecular forms of brain and atrial natriuretic peptides in transplanted human heart. Br J Biomed Sci 1994; 51: 316–20.
   PubMed Web of Science ®Google Scholar